Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes
- 21 March 2022
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 298, 120490
Abstract
No abstract availableKeywords
Funding Information
- Indian Council of Medical Research
This publication has 175 references indexed in Scilit:
- Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical updateActa Diabetologica, 2012
- Type 2 diabetes across generations: from pathophysiology to prevention and managementThe Lancet, 2011
- Long-Term Administration of the Histone Deacetylase Inhibitor Vorinostat Attenuates Renal Injury in Experimental Diabetes through an Endothelial Nitric Oxide Synthase-Dependent MechanismThe American Journal of Pathology, 2011
- Role of histone acetylation in the development of diabetic retinopathy and the metabolic memory phenomenonJournal of Cellular Biochemistry, 2010
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesNew England Journal of Medicine, 2008
- Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemiaJournal of Experimental Medicine, 2008
- Role of the Histone H3 Lysine 4 Methyltransferase, SET7/9, in the Regulation of NF-κB-dependent Inflammatory GenesJournal of Biological Chemistry, 2008
- Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetesProceedings of the National Academy of Sciences, 2008
- Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 DiabetesNew England Journal of Medicine, 2008
- Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studiesThe Lancet, 2008